Trial · NCT02139592
Adverse events85
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 85
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Lymphopenia | Blood and lymphatic system disorders | Brentuximab Vedotin Infusion | 22 | 284 | |
| other | Neutropenia | Blood and lymphatic system disorders | Brentuximab Vedotin Infusion | 153 | 284 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Brentuximab Vedotin Infusion | 17 | 284 | |
| other | Peripheral sensory neuropathy | Nervous system disorders | Brentuximab Vedotin Infusion | 129 | 284 | |
| other | Rash | Skin and subcutaneous tissue disorders | Brentuximab Vedotin Infusion | 15 | 284 | |
| other | Pyrexia | General disorders | Brentuximab Vedotin Infusion | 15 | 284 | |
| other | Infusion related reaction | Injury, poisoning and procedural complications | Brentuximab Vedotin Infusion | 31 | 284 | |
| serious | Bacteraemia | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 | |
| serious | Epstein-Barr virus infection | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 | |
| serious | Cytomegalovirus infection | Infections and infestations | Brentuximab Vedotin Infusion | 2 | 284 | |
| serious | Herpes zoster | Infections and infestations | Brentuximab Vedotin Infusion | 2 | 284 | |
| serious | Meningitis aseptic | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 | |
| serious | Fungal infection | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 | |
| serious | Pneumonia | Infections and infestations | Brentuximab Vedotin Infusion | 9 | 284 | |
| serious | Pyelonephritis | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 | |
| serious | Sepsis | Infections and infestations | Brentuximab Vedotin Infusion | 5 | 284 | |
| serious | Systemic candida | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 | |
| serious | Anal abscess | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 | |
| serious | Pneumonia fungal | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 | |
| serious | Device related infection | Infections and infestations | Brentuximab Vedotin Infusion | 1 | 284 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02139592/events